Balchem Ownership
| BCPC Stock | USD 152.84 5.53 3.49% |
Shares in Circulation | First Issued 1985-09-30 | Previous Quarter 32.5 M | Current Value 32.8 M | Avarage Shares Outstanding 27.3 M | Quarterly Volatility 4.2 M |
Balchem Stock Ownership Analysis
About 90.0% of the company shares are held by institutions such as insurance companies. The book value of Balchem was currently reported as 37.06. The company last dividend was issued on the 26th of December 2024. Balchem had 3:2 split on the 21st of January 2010. Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York. Balchem Cp operates under Specialty Chemicals classification in the United States and is traded on NASDAQ Exchange. It employs 1382 people. For more info on Balchem please contact Theodore Harris at 845 326 5600 or go to https://www.balchem.com.Besides selling stocks to institutional investors, Balchem also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Balchem's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Balchem's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Balchem Quarterly Liabilities And Stockholders Equity |
|
Balchem Insider Trades History
Less than 1% of Balchem are currently held by insiders. Unlike Balchem's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Balchem's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Balchem's insider trades
Balchem Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Balchem is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Balchem backward and forwards among themselves. Balchem's institutional investor refers to the entity that pools money to purchase Balchem's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Jpmorgan Chase & Co | 2025-03-31 | 479.7 K | Norges Bank | 2024-12-31 | 430.5 K | Schroder Investment Management Group | 2025-03-31 | 423.6 K | Northern Trust Corp | 2025-03-31 | 399 K | Charles Schwab Investment Management Inc | 2025-03-31 | 369.7 K | Congress Asset Management Company, Llp | 2025-03-31 | 358.5 K | Clearbridge Advisors, Llc | 2025-03-31 | 339.4 K | Grantham, Mayo, Van Otterloo & Co., Llc | 2025-03-31 | 296.3 K | William Blair Investment Management, Llc | 2025-03-31 | 286.1 K | Blackrock Inc | 2025-03-31 | 5 M | Vanguard Group Inc | 2025-03-31 | 3.9 M |
Balchem Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Balchem insiders, such as employees or executives, is commonly permitted as long as it does not rely on Balchem's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Balchem insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Balchem Outstanding Bonds
Balchem issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Balchem uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Balchem bonds can be classified according to their maturity, which is the date when Balchem has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Balchem Corporate Filings
| 18th of July 2025 Other Reports | ViewVerify | |
| 24th of June 2025 Other Reports | ViewVerify | |
8K | 20th of June 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 25th of April 2025 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Balchem offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Balchem's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Balchem Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Balchem Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Balchem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Specialty Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Balchem. If investors know Balchem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Balchem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.27 | Dividend Share 0.87 | Earnings Share 4.17 | Revenue Per Share | Quarterly Revenue Growth 0.045 |
The market value of Balchem is measured differently than its book value, which is the value of Balchem that is recorded on the company's balance sheet. Investors also form their own opinion of Balchem's value that differs from its market value or its book value, called intrinsic value, which is Balchem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Balchem's market value can be influenced by many factors that don't directly affect Balchem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Balchem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Balchem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Balchem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.